期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Bioinformatics Analysis on B cell Epitopes of Rice Allergen RAG1 被引量:1
1
作者 李燕芳 何颖 邹泽红 《Agricultural Science & Technology》 CAS 2012年第2期304-306,共3页
[Objective] To predict the secondary structure and B cell epitopes of the rice major allergen RAG1. [Method] The amino acid sequence of rice allergen RAG1 was acquired from Expasy protein database. The secondary struc... [Objective] To predict the secondary structure and B cell epitopes of the rice major allergen RAG1. [Method] The amino acid sequence of rice allergen RAG1 was acquired from Expasy protein database. The secondary structure of RAG1 was predicted by DNAStar Protean software with Gamier-Robson program, Chou-Fasman program and Karplus-Schulz program; the B cell epitopes of RAG1 was predicted with the Kyte Doolittle hydrophilic program, Emini surface accessibility program and Jameson-Wolf antigenic index program. [Result] The predictions on secondary structure and B cell epitopes showed that the regions of 33-44, 119-129, 155-163 were the dominant B cell epitopes. [Conclusion] This study predicted the potential dominant B cell epitopes in rice allergen RAG1 by comprehensive use of multi-methods and multi-parameters, and provided a theoretical basis for further researches on identification, antigen modification and epitope vaccine design of RAG1 B cell epitopes. 展开更多
关键词 Rice allergen RAG1 Secondary structure b cell epitopes
下载PDF
原发中枢神经系统弥漫性大B细胞淋巴瘤临床病理、分子遗传学改变及其与预后的相关性 被引量:4
2
作者 马志萍 艾尼瓦尔·巴巴依 +4 位作者 刘志英 师晓莉 崔文丽 张巍 李新霞 《中华病理学杂志》 CAS CSCD 北大核心 2016年第11期762-768,共7页
目的:探讨原发中枢神经系统弥漫性大B细胞淋巴瘤( DLBCL)的临床病理、免疫表型、与EB病毒相关性及分子遗传学改变,并分析相关预后因素。方法回顾性分析30例原发中枢神经系统DLBCL临床资料;采用HE染色及免疫组织化学EnVision法染色... 目的:探讨原发中枢神经系统弥漫性大B细胞淋巴瘤( DLBCL)的临床病理、免疫表型、与EB病毒相关性及分子遗传学改变,并分析相关预后因素。方法回顾性分析30例原发中枢神经系统DLBCL临床资料;采用HE染色及免疫组织化学EnVision法染色观察肿瘤组织病理学特点和免疫表型特征;原位杂交技术检测肿瘤EB病毒编码mRNA表达情况;荧光原位杂交技术检测肿瘤组织中bcl-2、bcl-6和C-MYC基因重排,并对所有患者进行随访。结果30例患者,男性18例,女性12例,男女比例1.5∶1.0。中位年龄53(24~76)岁。患者以局灶性神经功能缺损为主要临床表现。形态学以中心母细胞型为主,可见凝固性坏死及血管中心性-血管破坏性生长,有较多核分裂象和凋亡小体,常见血管周淋巴细胞套。免疫表型:生发中心( GCB)型6例,非GCB型24例,bcl-2、bcl-6、C-MYC蛋白表达率分别为53.3%(16/30)、80.0%(24/30)、20.0%(6/30)。荧光原位杂交检测bcl-2、bcl-6、C-MYC基因重排阳性率分别为3.3%(1/30)、16.7%(5/30)、6.7%(2/30)。仅1例检测出EBER阳性。国际预后指数(IPI)评分:0~1分19例(63.3%),2~3分11例(36.7%)。患者性别、民族、初次就诊时存在B症状、发病部位、血清乳酸脱氢酶、血沉、β2微球蛋白含量、bcl-2蛋白表达、bcl-6蛋白表达、Ki-67阳性指数及分子遗传学改变与预后均无统计学意义;发病年龄≤60岁组、功能状态(PS)评分0~1分组及IPI评分0~1分组患者预后较好(P<0.05);免疫分型GCB型组预后优于非GCB型组( P=0.013);术后加用大剂量甲氨蝶呤或阿糖胞苷化疗组的预后优于其他治疗方式组(P=0.006),术后电话随访,平均随访时间13.6个月,中位生存时间10个月,其中16例在1年内死亡,1年生存率为46.7%。结论年龄、临床功能状态评分、IPI评分、免疫分型及治疗方式与预后相关,原发中枢神经系统DLBCL患者病程进展迅速,1年内为死亡的高发时间,手术切除加用大剂量甲氨蝶呤或阿糖胞苷化疗是目前最佳的治疗方式。 展开更多
关键词 中枢神经系统肿瘤 淋巴瘤 大b.细胞弥漫性 免疫表型分型 基因 MYC 基因 bcl-2 预后
原文传递
不同临床分期弥漫性大B细胞淋巴瘤患者T淋巴细胞亚群及自然杀伤细胞含量差异及意义分析 被引量:1
3
作者 许昕 李庆山 +2 位作者 许艳丽 朱志刚 钟伟杰 《中国医师进修杂志》 2012年第18期4-6,共3页
目的了解不同临床分期弥漫性大B细胞淋巴瘤(DLBCL)患者外周血T淋巴细胞亚群及自然杀伤细胞(NK细胞)的含量并分析其临床意义。方法62例DLBCL患者按临床分期分为Ⅱ期组(21例)、Ⅲ期组(21例)、Ⅳ期组(20例),另选择健康体检者30... 目的了解不同临床分期弥漫性大B细胞淋巴瘤(DLBCL)患者外周血T淋巴细胞亚群及自然杀伤细胞(NK细胞)的含量并分析其临床意义。方法62例DLBCL患者按临床分期分为Ⅱ期组(21例)、Ⅲ期组(21例)、Ⅳ期组(20例),另选择健康体检者30例(对照组),采集入选者空腹外周血2ml,采用流式细胞术检测外周血T淋巴细胞亚群(CD3+、CD4+、CD8+)及NK细胞含量,并计算CD4+/CD8+。结果Ⅱ期组、Ⅲ期组CD3+明显低于对照组、Ⅳ期组[(854.6±276.9)×106/L、(823.3±211.5)×106/L比(1268.8±684.0)×10^6/L、(1332.7±571.2)×10^6L,P〈0.05];Ⅱ期组、Ⅲ期组、Ⅳ期组CD4+明显低于对照组[(433.5±240.7)×10^6/L、(423.8±234.8)×10^6/L、(423.04-143.8)×106/LH5(751.3±367.4)×10^6/L,P〈0.05];1V期组CD8+和CD4+/CD8+[(861.2±634.1)×10^6/L和0.5±0.3]明显高于对照组[(455.9±334.6)×106/L和2.1±1.3]、Ⅱ期组[(390.6±54.1)×10^6/L和1.0±0.8]、Ⅲ期组[(377.4±49.7)×106/L和0.9±0.6](P〈0.05);Ⅳ期组NK细胞明显低于对照组[(210.3±122.0)×10^6/L比(353.3±284.7)×10%,P〈0.05],且临床分期越高,NK细胞越低。结论随着临床分期的增加,DLBCL患者免疫抑制与紊乱加重,肿瘤负荷越大,NK细胞功能也越差。 展开更多
关键词 淋巴瘤 大b.细胞 弥漫性 T淋巴细胞亚群 杀伤细胞 天然
原文传递
Invasive front of colorectal cancer:Dynamic interface of pro-/anti-tumor factors 被引量:9
4
作者 Inti Zlobec Alessandro Lugli 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第47期5898-5906,共9页
Tumor-host interaction at the invasive front of colorectal cancer represents a critical interface encompassing a dynamic process of de-differentiation of colorectal carci-noma cells known as epithelial mesenchymal tra... Tumor-host interaction at the invasive front of colorectal cancer represents a critical interface encompassing a dynamic process of de-differentiation of colorectal carci-noma cells known as epithelial mesenchymal transition (EMT). EMT can be identified histologically by the presence of "tumor budding" ,a feature which can be highly specific for tumors showing an inf iltrating tumor growth pattern. Importantly,tumor budding and tumor border configuration have generated considerable interest as additional prognostic factors and are also recognized as such by the International Union Against Cancer. Evidence seems to suggest that the presence of tumor budding or an infiltrating growth pattern is inversely correlated with the presence of immune and inflammatory responses at the invasive tumor front. In fact,several tumor-associated antigens such as CD3,CD4,CD8,CD20,Granzyme B,FOXP3 and other immunological or inflammatory cell types have been identified as poten-tially prognostic in patients with this disease. Evidence seems to suggest that the balance between protumor (including budding and inf iltrating growth pattern) and anti-tumor (immune response or certain inflammatory cell types) factors at the invasive front of colorectal cancer may be decisive in determining tumor progression and the clinical outcome of patients with colorectal cancer. On one hand,the inf iltrating tumor border configuration and tumor budding promote progression and dissemination of tumor cells by penetrating the vascular and lymphatic vessels. On the other,the host attempts to fend off this attack by mounting an immune response to protect vascular and lymphatic channels from invasion by tumor buds. Whereas standard pathology reporting of breast and prostate cancer involves additional prognostic features,such as the BRE and Gleason scores,the ratio of pro-and anti-tumor factors could be a promising approach for the future development of a prognostic score for patients with colorectal cancer which could complement tumor node metastasis staging to improve the clinical management of patients with this disease. 展开更多
关键词 Colorectal cancer PROGNOSIS Tumor invasive front Tumor budding Tumor growth pattern Tumor infiltrating lymphocytes Tumor immunity Microsatellite instability
下载PDF
Cyprinid phylogeny based on Bayesian and maximum likelihood analyses of partitioned data:implications for Cyprinidae systematics 被引量:2
5
作者 WANG XuZhen GAN XiaoNi +2 位作者 LI JunBing MAYDEN Richard L. HE ShunPing 《Science China(Life Sciences)》 SCIE CAS 2012年第9期761-773,共13页
Cyprinidae is the biggest family of freshwater fish, but the phylogenetic relationships among its higher-level taxa are not yet fully resolved. In this study, we used the nuclear recombination activating gene 2 and th... Cyprinidae is the biggest family of freshwater fish, but the phylogenetic relationships among its higher-level taxa are not yet fully resolved. In this study, we used the nuclear recombination activating gene 2 and the mitochondrial 16S ribosomal RNA and cytochrome b genes to reconstruct cyprinid phylogeny. Our aims were to (i) demonstrate the effects of partitioned phylo- genetic analyses on phylogeny reconstruction of cyprinid fishes; (ii) provide new insights into the phylogeny of cyprinids. Our study indicated that unpartitioned strategy was optimal for our analyses; partitioned analyses did not provide better-resolved or -supported estimates of cyprinid phylogeny. Bayesian analyses support the following relationships among the major mono- phyletic groups within Cyprinidae: (Cyprininae, Labeoninae), ((Acheilognathinae, ((Leuciscinae, Tincinae), Gobioninae)), Xenocyprirlinae). The placement of Danioninae was poorly resolved. Estimates of divergence dates within the family showed that radiation of the major cyprinid groups occurred during the Late Oligocene through the Late Miocene. Our phylogenetic analyses improved our understanding of the evolutionary history of this important fish family. 展开更多
关键词 CYPRINIDAE PHYLOGENY molecular dating partitioned analyses
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部